Article Text

other Versions

PDF
Systematic review with meta analysis
Blood pressure-lowering treatment should be based on the level of cardiovascular risk, not on the level of blood pressure
  1. Malcolm R Law
  1. Queen Mary University of London, Wolfson Institute of Preventive Medicine, London, UK
  1. Correspondence to: Dr Malcolm R Law, Queen Mary University of London, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK; m.r.law{at}qmul.ac.uk

Statistics from Altmetric.com

Commentary on:

Context

The 2008 report of the Health Survey for England included a chapter on ‘cholesterol’ (with no mention of ‘hypercholesterolemia’) and another on ‘hypertension’ (with no mention of ‘blood pressure’).1 This dichotomy echoed a prevalent view. Treatment guidelines advocated blood pressure-lowering drugs for everybody with blood pressure above a certain threshold (somewhat arbitrarily defined) but not for people with blood pressure below the threshold. There was a view (unsupported by evidence) that below the threshold reducing blood pressure did not reduce risk. However, cholesterol-lowering drugs were advocated for everyone at higher risk, irrespective of pretreatment cholesterol; the relationship with cardiovascular disease was correctly judged to be continuous.

There is strong evidence that blood pressure-lowering drugs should also be used in …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.